Concordia Pharmaceuticals Inc.
Records under this name other than patents Concordia Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Concordia Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,338,481 | Alkoxyalkyl S-Prenylthiosalicylates for Treatment of Cancer Formerly held Lapsed on the fee record Ended Dec 25, 2020 · High confidence | Lapsed on the fee record | Ended Dec 25, 2020 | High confidence |
| US 8,088,756 | Methods and Compositions for Oral Delivery of FTS Formerly held Lapsed on the fee record Ended Jan 3, 2020 · High confidence | Lapsed on the fee record | Ended Jan 3, 2020 | High confidence |
| US 6,030,642 | Extended release clonidine formulation (capsule) Term ended Term ended Jun 27, 2017 · USPTO record | Term ended | Term ended Jun 27, 2017 | USPTO record |
| US 5,484,607 | Extended release clonidine formulation Term ended Term ended no later than Jan 16, 2016 · Low confidence | Term ended | Term ended no later than Jan 16, 2016 | Low confidence |
| US 5,589,190 | Sustained-release compositions of alfuzosin hydrochloride Term ended Term ended no later than Dec 31, 2016 · Low confidence | Term ended | Term ended no later than Dec 31, 2016 | Low confidence |
| US 5,763,449 | Pleasant-tasting aqueous liquid composition of a bitter-tasting drug Term ended Term ended no later than Jun 9, 2018 · Low confidence | Term ended | Term ended no later than Jun 9, 2018 | Low confidence |
| US 5,869,100 | Extended release clonidine formulation (tablet) Term ended Term ended no later than Feb 9, 2019 · Low confidence | Term ended | Term ended no later than Feb 9, 2019 | Low confidence |